Gene Query: ATXN3

Dataset Description Geneva Score
Virus Mimicry in the Tumor Microenvironment Activates RIG-I Through Unshielding of Endogenous RNA in Exosomes [RNA-Seq] 88.29
Ectoderm specification of H1 human embryonic stem cells 70.08
Exogenous pyruvate represses histone gene expression to inhibit cancer cell proliferation via the NAMPT-NAD + -SIRT1 pathway 61.33
mRNA expression in iPS cells generated by a synthetic self-replicative RNA 61.03
Improved LCL to iPSC reprogramming: RNA Analysis of LCLs, reprogrammed iPSCs, and differentiated NSCs reveal potential regulatory and functional processes involved in these cellular transitions. 52.52
Error-free and error-prone DNA repair gene expression through reprogramming and passage in human iPS cells 44.51
A Werner syndrome stem cell model unveils heterochromatin alterations as a driver of human aging 44.36
Generation of targeted homozygosity in the genome of human induced pluripotent stem cells 41.62
MULTI-seq: Universal sample multiplexing for single-cell RNA sequencing using lipid-tagged indices 38.59
Global expression profiles in cardiac progenitor cells generated by ISX-9 38.33
Global mRNA expression profile in cardiac progenitor cells generated by ISX-9 38.33
ETS family proteins bind glucocorticoid receptor: relevance for treatment of Ewing sarcoma 37.93
The LIN28B/let-7 axis is a novel therapeutic pathway in Multiple Myeloma 37.91
Radiomic and gEnomic approaches for the enhanced DIagnosis of REnal Cancer (REDIRECt): A translational pilot study 37.08
TimeLapse-seq: adding a temporal dimension to RNA sequencing through nucleoside recoding 36.5
High-depth RNA sequencing of isogenic wild-type, PIK3CA-WT/H1047R and PIK3CA-H1047R/H1047R human iPSCs 35.59
The RNA helicase DDX6 regulates self-renewal and differentiation of human and mouse stem cells [RNA-seq2] 35.39
Modeling Trilateral Retinoblastoma using Human Embryonic Stem Cells 35.26
Genomic analysis of human parthenogenetic haploid ESCs (hPGES), normal human ESCs(H9) and human forskin fibroblast 34.4
mRNA expression data from human parthenogenetic haploid ESCs (hPGES), normal ESCs (H9) and human fibroblast 34.4
Transcriptome analysis of V336Y mutant mitochondrial ribosomal protein in human HEK293 cell line 33.88
RNA sequencing analysis of human embryonic stem cells and axial progenitors 33.53
Detailed genomic and molecular characterization of Indian induced pluripotent stem cell lines 33.16
The effect of Foxc1 deficiency on undifferentiated and differentiated human primary keratinocytes 32.7
NRDE2 negatively regulates nuclear exosome functions 31.34
RNA sequencing of GLO1-depleted MDA-MB-231 breast cancer cells 30.43
Differentially expressed vascular development genes for iPSC-ECs from CDI 30.18
Transcriptome analysis of human embryonic stem cells (hESCs) and human fibroblasts upon rapamycin 29.93
A bioinformatics approach reveals novel mechanisms of the OVOL transcription factors in the regulation of epithelial-mesenchymal cell programming and cancer progression. 28.56
RNA-seq of UGP2 mutant human embryonic stem cells and in vitro differentiated neural stem cells 27.47
Apoptotic endothelial cells release small extracellular vesicles loaded with immunostimulatory viral-like RNAs 27.37
Cell-specific expression and function patterns of microRNA-150-5p in liver fibrogenesis 27.14
Gene expression profile of human iPSC-derived nephron progenitor cells 27.1
Differential expression of human parthenogenic stem cells, neural stem cells and DA progenitors. 27.01
LncRNA-GAS5 negative regulation of YAP-target genes expression 26.04
Biological effect of chronic mistranslation in mammalian cells 25.56
The Unfolded Protein Response Regulator, ATF6, Promotes Mesodermal Differentiation 25.36
NET-CAGE Characterizes the Dynamics and Topology of Human Transcribed Cis-regulatory Elements 25.34
Gene expression changes caused by KRAS in MCF-10A 25.25
Muscleblind-like 1 suppresses breast cancer metastatic colonization and stabilizes metastasis suppressor transcripts 24.6
MBNL1-dependent modulation of gene expression in MDA-MB-231 breast cancer cells 24.6
A myogenic double reporter human pluripotent stem cell line allows prospective isolation of skeletal muscle progenitors 24.17
miR-93 Targets in Human Endothelial Cells 23.84
Impact of flanking chromosomal sequences on localization and silencing by the ncRNA XIST 22.79
High-throughput RNA sequencing on circular RNA profiles of human pancreatic cancer cell lines and gemcitabine resistant pancreatic cancer cell lines. 22.68
Identification of elevated A-to-I editing sites due to expression of an active ADAR3 mutant in human glioblastoma cells 22.12
Transcriptional alteration after ionizing radiation exposure in human fibroblasts, iPSCs and NPCs 21.85
Solid phase chemistry to covalently and reversibly capture thiolated RNA 21.57
Human cell line and subcutaneous tumor 21.17
Developmental origins define epigenomic differences between subcutaneous and visceral adipocytes 21.04
Inheritable Silencing of Endogenous Genes by Hit-and-Run Targeted Epigenetic Editing 20.83
Safeguarding nucleolar homeostasis by CBX4 alleviates senescence and osteoarthritis 20.82
Genes altered in expression by Cisplatin treatment in lung cancer cell lines 20.73
Gene expression analysis of BRD4 knockdown in HT-29 and HCT116 cells 19.82
The interplay between SOX4 and SMAD3 in the context of breast cancer 19.45
Differential roles of human PUS10 in miRNA processing and tRNA pseudouridylation 19.26
A Brain Penetrant Mutant IDH1 Inhibitor Provides In Vivo Survival Benefit 19.19
Circular RNAs in the mammalian brain are highly abundant, conserved, and dynamically expressed 18.88
B cells expressing the IgA receptor FcRL4 participate in the autoimmune response in patients with rheumatoid arthritis 18.86
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [UNSWCD] 18.53
A Surveillance System of Active Enhancers by a RACK7-histone Demethylase Complex 18.42
Rapid neurogenesis through transcriptional activation in human stem cell (RNA-Seq) 18.1
Transcriptional profiling of LS1034 cells treated with tepoxalin 18.04
GCTM-5 positive and negative cells in pancreatic adenocarcinoma cell lines 18.01
MEIS1 regulates hematopoiesis in hPSCs 17.95
Gene target specificity of the Super Elongation Complex (SEC) family: How HIV-1 Tat employs selected SEC members to activate viral transcription 17.53
Cell cycle dynamics of human pluripotent stem cells primed for differentiation 17.5
Survival of pancreatic cancer cells lacking KRAS function 17.23
Transcriptome profiling of H1-iCas9 cells grown on laminin and on MEFs 17.08
RNA-seq melanoma 16.94
ARID1A and ARID1B loss in HCT116 cells 16.9
Human iPSC-based Modeling of Late-Onset Disease using Progerin-induced Aging 16.77
Nuclear Actin Regulates Inducible Transcription by Enhancing RNA Polymerase II Clustering 16.68
RNA-sequencing of cells derived from the site of inflammation of Juvenile Idiopathic Arthritis patients 16.62
Epigenetic profiling and RNA-sequencing of Juvenile Idiopathic Arthritits (JIA) patients 16.62
Differentially expressed (DE) genes analysis in synovial fluid mesenchymal stem cells (SF-MSCs), SF-MSC derived iPSCs and iPSC derived MSCs (iPSC-MSCs) 16.57
Identification of PRMT5-dependent genes in ESA+CD24lowCD44+ MCF7 cells 16.54
Regulators of cellular heterogeneity in basal-like breast cancer influence symmetric versus asymmetric division rates (shRNA targeting) 16.53
Codon usage optimization in pluripotent embryonic stem cells [RNA-seq] 16.43
The RNA-binding profile of Acinus, a peripheral component of the Exon junction complex, reveals its role in splicing regulation 16.33
Progressive motor neuron pathology and the role of astrocytes in a human stem cell model of VCP-related ALS 16.31
Analysis of the Clustered Protocadherin (cPcdh) Locus in Human Pluripotent Stem and Derived Cells [RNA-seq II our of II] 16.16
Alu RNA modulates the expression of cell cycle genes in human fibroblasts 16.05
Transcriptomic profiling of HeLa cells infected with Salmonella Typhimurium 16.01
ChIPseq and RNAseq analysis of T47D cells with/without silencing TRPS1/CHD4 15.93
RNA-seq in untreated and flagellin-treated Human Intestinal Myofibroblast cells (HIMF) 15.9
Differentiation enhances Zika virus infection in neuronal brain cells 15.9
Transcriptomic analyssis following EHMT1/2 inhibition 15.8
RNA-sequencing based transcriptome-wide expression profiling of Cynomolgus monkey and human IPSCs in vitro differentiated into endothelial cells 15.61
24hr CA treatment vs. DMSO in HCT116 cells (from 'Identification of CDK8 and CDK19 substrates in human cells using cortistatin A and quantitative phosphoproteomics') 15.54
Metastasis in triple negative breast cancer is dependent on ΔNp63/CXCL2/CCL22-mediated recruitment of myeloid-derived suppressor cells 15.48
ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice 15.45
ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice [HCT116_RNA-seq] 15.45
Ultracentifugation and nanoscale deterministic lateral displacement (nanoDLD) of samples for exRNA analysis 15.33
Genome wide expression change by RNF168 knocking down in NEC cells 15.3
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-Seq of LMNA KD) 15.21
iRNA-seq: Computational method for genome wide assessment of acute transcriptional regulation from total RNA-seq data 15.2
Isogenic patient-derived human iPSCs, wild-type or heterozygous for PIK3CA-E418K 15.18
Reprogramming by de-bookmarking somatic transcriptional program via targeting the BET bromodomains 14.99
Insights into snoRNA biogenesis and processing from PAR-CLIP of snoRNA core proteins and small RNA sequencing 14.99
Extracellular matrix hydrogel derived from decellularized tissues enables endoderm organoids culture 14.92
Coding mutations and loss-of-imprinting in human pluripotent cells derived by nuclear transfer and defined factors 14.92
Coding mutations and loss-of-imprinting in human pluripotent cells derived by nuclear transfer and defined factors [RNA-Seq] 14.92
Dynamic developmental signaling logic underlying lineage bifurcations during human endoderm induction and patterning from pluripotent stem cells [Endoderm RNA-seq and ChIP-seq data sets] 14.92
Dynamic developmental signaling logic underlying lineage bifurcations during human endoderm induction and patterning from pluripotent stem cells 14.92
Identification of PAX7-induced transcriptional changes and PAX7 genomic binding during skeletal myogenic differentiation of H9 embryonic stem cells 14.87
MRTF activates TEAD-YAP target gene expression 14.86
Single-cell epigenomics maps the continuous regulatory landscape of human hematopoietic differentiation 14.85
Single-cell epigenomics maps the continuous regulatory landscape of human hematopoietic differentiation [bulk RNA-Seq] 14.85
Dynamic and stable enhancer-promoter contacts regulate terminal differentiation 14.8
Dynamic and stable enhancer-promoter contacts regulate terminal differentiation [RNA-Seq] 14.8
Deciphering the ‘m6A code’ via quantitative profiling of m6A at single-nucleotide resolution 14.79
Deciphering the ‘m6A code’ via quantitative profiling of m6A at single-nucleotide resolution [III] 14.79
The RNA helicase DDX39B regulates IL7R alternative splicing reducing the risk of Multiple Sclerosis 14.69
High-Throughput Drug Screening identifies Pazopanib and Clofilium tosylate as effective treatments for malignant rhabdoid tumors 14.69
Whole transcriptome sequencing identifies increased CXCR2 expression in PNH granulocytes 14.58
CRISPR/Cas9-mediated ASXL1 mutation in U937 cells perturbs myeloid differentiation 14.48
RNA-sequencing and MeDIP-sequencing of shSRC-1 and shNT tamoxifen treated LY2 cells 14.26
RNA-sequencing of shSRC-1 and shNT tamoxifen treated LY2 cells 14.26
Next generation sequencing of small RNAs isolated from exosomes in human semen 14.25
Direct identification of endogenous SMG6 targets and a preferred motif spanning SMG6 cleavage sites by parallel analysis of RNA ends in human cells 14.24
Distinct and shared functions of ALS-associated TDP-43, FUS, and TAF15 revealed by comprehensive multi-system integrative analyses [RNA-Seq_human] 14.14
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 [RNA-seq] 14.13
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 14.13
Transcriptomic analysis of T84 colon carcinoma cell line treated with trametinib, JQ1 or their combination 14.11
DUX4-induced dsRNA and MYC mRNA Stabilization Activate Apoptotic Pathways in Human Cell Models of Facioscapulohumeral Dystrophy 14.08
12hr 5-FU treatment vs. DMSO in SJSA cells (from 'A kinase independent role for CDK19 in p53 response') 14.04
Extensive remodeling of DC function by rapid maturation-induced epigenetic gene silencing 13.94
Extensive remodeling of DC function by rapid maturation-induced epigenetic gene silencing [RNA-Seq] 13.94
Sequencing of messenger RNAs with N6-methyladenosine modifications in acute myeloid leukemia (AML) with and without forced expression of FTO 13.92
Cellular response to hepatitis E virus (HEV) infection 13.7
Generation of a Panel of Induced Pluripotent Stem Cells From Chimpanzees: a Resource for Comparative Functional Genomics (RNA-Seq) 13.7
Generation of a Panel of Induced Pluripotent Stem Cells From Chimpanzees: a Resource for Comparative Functional Genomics 13.7
Integrative transcriptome-wide analyses reveal critical HER2-regulated mRNAs and lincRNAs in HER2+ breast cancer 13.6
RNA Sequencing Facilitates Quantitative Analysis of Transcriptomes of human mesenchymal stem cells differentiation from human embryonic stem cells and adult bone marrow mesenchymal stem cells 13.51
Reassessment of Exosome Composition 13.51
Genome-wide CRISPR-Cas9 screen identifies druggable synthetic lethality between LSD1 and MTORC1 in MLL-translocated AML 13.48
SMN2 splicing modifiers improve motor function and longevity in mice with spinal muscular atrophy 13.47
Modeling and characterization of the dynamic gene regulatory networks underlying cancer drug resistance based on time-course RNA-seq data 13.42
Verification and rectification of cell type-specific splicing of a Seckel syndrome-associated ATR mutation using iPS cell model 13.41
RIG-I and MDA5 fRIP during KSHV lytic reactivation 13.33
Transcriptome analysis of PRMT6 knock-out in NT2/D1 cells 13.15
Genomic location of PRMT6-dependent H3R2 methylation is decisive for the transcriptional outcome of associated genes 13.15
Comparative total RNA and mRNA sequencing and systems analysis reveals nascent transcriptional response to early HIV-1 infection in a CD4+ T cell line 13.15
Bromodomain-containing Protein 4 (BRD4) is Required for the Maintenance of a Mammary Epithelial Phenotype [RNA-Seq] 12.89
Bromodomain-containing Protein 4 (BRD4) is Required for the Maintenance of a Mammary Epithelial Phenotype 12.89
HNF1A deficiency impairs β-cell fate, granule maturation and function 12.85
Cell Type-Specific Chromatin Signatures Underline Regulatory DNA Elements in Human Induced Pluripotent Stem Cells and Somatic Cells 12.81
SERPINA3- a novel keratinocyte differentiation promotor mediates epidermal barrier repair response in psoriatic lesion 12.67
Transcriptome-wide study of the response of human trabecular meshwork cells to the substrate stiffness increase 12.63
RNA-sequencing time course of Human Intestinal Epithelial Cells (HIECs) following knockdown of miR-30bcd using complementary locked nucleic acids 12.53
The myelin protein PMP2 is regulated by SOX10 and drives melanoma cell invasion 12.5
BET bromodomain inhibitor iBET151 impedes human ILC2 activation and prevents experimental allergic lung inflammation 12.43
Global Mapping of Human RNA-RNA Interactions 12.41
FMRP facilitates the nuclear export of N6-methyladenosine-containing mRNAs 12.4
Examining serotonergic neuron differentiation from human iPSCs 12.37
Non-transmissible measles virus vector with segmented RNA genome establishes different types of iPSCs from hematopoietic cells 12.34
BI Human Reference Epigenome Mapping Project 12.32
Loss of histone macroH2A1 in hepatocellular carcinoma cells promotes paracrine-mediated chemoresistance and CD4+CD25+ T regulatory cells activation 12.26
Mechanistic Model-Guided Study of Embryonic Morphogenesis 12.18
Similarity of therapeutic networks induced by a multi-component herbal remedy in neurovascular unit cells 12.13
COMBINING BET AND MEK INHIBITORS SYNERGISTICALLY TARGETS NRAS MUTANT MELANOMA 12.12
m6A level and isoform characterization sequencing (m6A-LAIC-seq) reveal the census and complexity of the m6A epitranscriptome 12.12
LMO1 Synergizes with MYCN to Promotes Neuroblastoma Initiation and Metastasis 12.1
AhR activity directs BRAF inhibitors resistance in metastastic melanoma 11.98
Heterozygous and homozygous knock-in of PIK3CA-H1047R into human iPSCs 11.67
TALENs-mediated gene disruption of FLT3 in leukemia cells: Using genome-editing approach for exploring the molecular basis of gene abnormality 11.64
Targets of CDK12 on ZR-75-30 breast cancer cells (RNA-seq) 11.64
RNA-seq analysis of CRISPR/Cas9 generated human BMPR2 deficient endothelial cell lines harboring mutations characteristic for hereditary pulmonary hypertension (HPAH) 11.6
Cell-to-cell variation in defective virus expression and effect on host response during influenza virus infection 11.59
Genetic disarray follows mutant KLF1-E325K expression in a congenital dyserythropoietic anemia patient 11.53
Derivation and differentiation of haploid human embryonic stem cells [RNA-Seq 1] 11.52
RNA-seq analysis to identify the genes regulated by p53-SET interplay 11.43
Self-organized amniogenesis by human pluripotent stem cells in a biomimetic implantation-like niche 11.39
TFPa/HADHA is required for fatty acid beta-oxidation and cardiolipin re-modeling in human cardiomyocytes 11.24
The Polycomb Repressor Complex 1 Drives Double-Negative Prostate Cancer Metastasis by Coordinating Stemness and Immune Suppression 11.21
TMED9-gated CNIH4 and TGFa signaling promotes pro-metastatic states in human primary colon cancer cells 11.2
Enhancing human kidney organoid differentiation from pluripotent stem cells with high-throughput automation 11.14
CDK12 catalytic activity is rate-limiting for RNAPII processivity on core DNA replication genes and G1/S progression (3' RNA) 11.03
Widespread N6-methyladenosine-dependent RNA Structural Switches Regulate RNA-Protein Interactions 10.99
Patient-derived xenograft platform for metastatic melanoma: a model for studying resistance to targeted therapy. 10.99
Postnatal lipids drive hepatocyte maturation 10.95
The antineoplastic drug, trastuzumab, dysregulates metabolism in iPSC derived cardiomyocytes. 10.94
A Suv39H1-low chromatin state drives migratory cell populations in cervical cancer 10.9
A Suv39H1-low chromatin state drives migratory cell populations in cervical cancer [RNA-Seq] 10.9
The regulartory role of ZCCHC24 in splicing machinery 10.89
Derivation and differentiation of haploid human embryonic stem cells 10.8
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia 10.77
Co-expression of CD163 and CD141 Identifies Human Circulating IL-10-Producing Dendritic Cells (DC-10) [RNA-seq] 10.76
Co-expression of CD163 and CD141 Identifies Human Circulating IL-10-Producing Dendritic Cells (DC-10) 10.76
Changes in chromatin accessibility and gene expression induced by overexpression of ONECUT transcription factors 10.75
Profiling of gene expression using RNA-Seq in fibroblasts, iPSCs, iPSC-derived neurons and cells overexpressing Onecut transcription factors 10.75
RNA-Seq analysis of neurons derived from induced pluripotent stem cells reprogrammed from dental pulp 10.63
Regulation of DNA methylation landscape in human somatic cell reprogramming by miR-29 family 10.62
Regulation of DNA methylation landscape in human somatic cell reprogramming by miR-29 family (RNA-seq) 10.62
BET-Bromodomain Inhibitors Engage The Host Immune System And Regulate Expression Of The Immune Checkpoint Ligand PD-L1 [3mRNA-seq] 10.58
BET-Bromodomain Inhibitors Engage The Host Immune System And Regulate Expression Of The Immune Checkpoint Ligand PD-L1 10.58
SnapShot-Seq: a method for extracting genome-wide, in vivo mRNA dynamics from a single total RNA sample 10.56
The m 6 A-methylase complex recruits TREX and regulates mRNA export. 10.51
Characterization and therapeautic application of mesenchymal stem cells with neuromesodermal origin from human pluripotent stem cells 10.5
Exploring the RNA landscape of endothelial exosomes 10.49
A comparison of gene expression between lesional and non-lesional derived keratinocytes of Hailey-Hailey disease patients. 10.47
mRNA sequencing of the global effect of SOX2 on gene expression in hESC and hESC derived NPCs. 10.43
Epigenetic siRNA and chemical screens identify SETD8 inhibition as a new therapeutic strategy of p53 reactivation in high-risk Neuroblastoma. 10.41
RNA Sequencing Facilitates Quantitative Analysis of Transcriptomes of H1 and H1 after SNAI1 deletion at Day2 after human early hematopoietic differentiation . 10.41
Comparison of single-cell transcriptomics quality between unfixed cells and cells that were fixed and mock stained according to the RAID procedure 10.37
Human induced pluripotent stem cell-derived vocal fold mucosa mimics development and responses to smoke exposure 10.35
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 [HET] 10.31
Next Generation Sequencing of human SMA and healthy control Motor Neurons 10.28
RNAseq data from SCCOHT1 and OVCAR8 ovarian cancer cells treated with BET inhibitors 10.26
Next Generation Sequencing Analysis of human embryonic stem cells derived MESP1-mTomato reporter cells 10.24
Stretch-Enhancers Delineate Disease-Associated Regulatory Nodes in T Cells 10.2
Tyrosine-1 of RNAPII CTD controls global termination of gene transcription in mammals 10.14
In vivo generation of post-infarct human cardiac muscle by laminin-promoted cardiovascular progenitors [LN-521 or LN-521+LN-221] 10.13
Differential expression of long non‑coding RNA and mRNA in children with Henoch‑Schönlein purpura nephritis 10.06
Sequencing of freshly produced RNA following exposure of cells to DNA damage-inducing UV mimetic 4-hydroxyaminoquinolone (4-NQO) 10.04
High-efficiency RNA-based reprogramming of human primary fibroblasts 10.03
Cancer Associated Fibroblasts are defined by a core set of epigenome changes that contribute to the tumor phenotype [RNA-seq] 10.01
Cancer Associated Fibroblasts are defined by a core set of epigenome changes that contribute to the tumor phenotype 10.01
Genome-wide identification of cancer-specific alternative splicing in circRNA 10.01
Species-specific maturation profiles of human, chimpanzee and bonobo neural cells 9.99
Dissecting the dynamics of signaling events in the BMP,WNT and NODAL cascade during self-organized fate patterning in human gastruloids 9.87
Molecular Hallmarks of Experimentally Acquired Immunity to Malaria [Pilot Study] 9.86
Transcriptomic Dynamics during Differentiation Process of Human Pluripotent Cells into Hepatocyte-like Cells 9.84
Involvement of Condensin in Cellular Senescence through Gene Regulation and Compartmental Reorganization 9.83
FTSEC cells (FT190 and FT194 cell lines) transduced with shRNA to knockdown RNF20 or with control shRNA 9.83
Gene expression profile in FTSEC cells (FT190 and FT194 cell lines) transduced with shRNA to knockdown RNF20 or with control shRNA using RNA-seq. 9.83
Selective expansion of myeloid and NK cells in humanized mice yields human-like vaccine responses (Experiment 1: RNA-seq) 9.82
Transcriptomic profiling of O-GlcNAcylated mRNA-protein complexes by using OG-CLAP in HeLa cells. 9.73
An integrative network biology analysis identifies miR-508-3p as the determinant and a prognosis biomarker of the mesenchymal subtype ovarian cancer 9.72
Loss of ANCO1 repression of AIB1/YAP drives breast cancer progression 9.71
Identification of a unique subtype of lung squamous cell carcinoma defined by SOX2 and a neural differentiation factor BRN2 9.7
Identification of a unique subtype of lung squamous cell carcinoma defined by SOX2 and a neural differentiation factor BRN2 [RNA-seq] 9.7
Messenger RNA expression after silencing or inhibition of MEN1in MCF-7 breast cancer cells 9.67
Subcellular RNA fractions of HSV-1 infected primary human fibroblasts 9.65
The Role of Histone H3 Lysine 36 Methylation in Reprogramming of fibroblasts and on Induced Pluripotent stem Cell Generation 9.61
Metastasis in triple-negative breast cancer 9.53
Functional and genomic characterization of a xenograft model system for the study of metastasis in triple-negative breast cancer. 9.53
Transcriptomic hallmarks of tumor plasticity and stromal interactions in brain metastasis [MultiDisease] 9.49
Mitochondrial dsRNA triggers antiviral signalling in humans 9.47
Splicing towards noncoding isoforms in colorectal carcinoma is associated with tumor hypoxia and the DNA damage response 9.46
DNA Methylation Reprograms Metabolic Gene Expression in End-Stage Human Heart Failure 9.4
The transcriptomic landscape of MAIT cell development in the thymus (NN41 RNAseq data set) 9.4
Cystathionine-β-Synthase Promotes Colon Carcinogenesis 9.36
Episomal HBV persistence within transcribed host nuclear chromatin compartments involves HBx 9.35
RNA-seq of resting and activated CD4+ T cells +-JQ1 9.32
Effects of Cardiac Glycosides on RNA Expression in Prostate Cancer LNCaP-abl Cells 9.28
Genome-wide RNA-seq from GALNT14-depleted and GALNT14 overexpressing MDA-MB-231 LM2 and Par cells 9.25
N6-methyladenosine mRNA marking promotes selective translation of regulons required for human erythropoiesis[Ribosome Profiling] 9.21
RNA editing in nascent RNA affects pre-mRNA splicing 9.19
Transcriptome analysis of total RNA in human osteosarcoma cell line U2OS before and after inhibition of zinc finger protein ZNF768 9.19
An evolutionarily conserved function of polycomb silences the MHC class I antigen presentation pathway and enables immune evasion in cancer [RNA-Seq] 9.18
An evolutionarily conserved function of polycomb silences the MHC class I antigen presentation pathway and enables immune evasion in cancer 9.18
The RNA binding protein IGF2BP3 promotes hematopoietic progenitor cell proliferation by targeting leukemogenic pathways 9.16
Molecular mechanism underlying increased ischemic damage in the ALDH2*2 genetic polymorphism using a human iPSC model system 9.15
Nucleotide excision repair capacity increases during differentiation of human embryonic carcinoma cells into neurons and muscle cells 9.13
ARID1A and PI3-Kinase pathway mutations in the endometrium drive epithelial transdifferentiation and collective invasion 9.11
Characterisation of HIF-dependent alternative isoforms in pancreatic cancer 9.08
Uridylation by TUT4 and TUT7 marks mRNA for degradation 9.06
Improved post thaw function and genetic changes for mesenchymal stromal cells cryopreserved using multicomponent osmolyte solutions 9.04
Stem and effector CD8 T-cells from human cancers 9.02
Super-enhancer-driven CCAT1 is co-activated by SOX2 and TP63 and promotes squamous cancer from esophagus, head and neck and lung [RNA-seq] 9.0
Super-enhancer-driven CCAT1 is co-activated by SOX2 and TP63 and promotes squamous cancer from esophagus, head and neck and lung 9.0
Adaptation of the Kinome Promotes Resistance to BET Bromodomain Inhibitors in Ovarian Cancer 8.95
scRNASeq analysis of cycling cardiomyocytes 8.94
SLIGRL-induced gene expression changes in NHEK cells 8.92
EGFR Mutation Promotes Glioblastoma Through Epigenome and Transcription Factor Network Remodeling 8.87
Gene expression profiling of leukemia cells following asparagine depletion 8.84
Microprocessor mediates transcription termination in long noncoding microRNA genes 8.83
LED, a long non-coding RNA activator of enhancer RNAs, is hypermethylated in human cancers 8.8
RNA-seq of SCLC PDX models treated with EP 8.69
RNA m5C Methylation in breast cancer using MeRIP-Seq 8.67
RNA-seq analysis of primary patient samples to characterize the CNS leukemia 8.66
Transcriptome analysis of CNS leukemia 8.66
MenSCs inhibit HCC growth through oncogenic pathway suppression via regulating 5-hmC in enhancer elements 8.65
MenSCs inhibit HCC growth through oncogenic pathway suppression via regulating 5-hmC in enhancer elements [RNA-seq] 8.65
Opposing Effects of Cyclooxygenase-2 (COX-2) on Estrogen Receptor β (ERβ) Response to 5α-reductase Inhibition in Prostate Epithelial Cells 8.62
5hmC dynamically correlated with enhancer's activities during hES-to-Pancreatic endoderm cell differentiation 8.61
5hmC dynamically correlated with enhancer's activities during hES-to-Pancreatic endoderm cell differentiation (RNA-Seq) 8.61
Distinct structural classes of activating FOXA1 alterations in prostate cancer progression 8.59
Distinct structural classes of activating FOXA1 alterations in prostate cancer progression [RNA-Seq] 8.59
Functional Cardiac Fibroblasts Derived from Human Pluripotent Stem Cells via Second Heart Field Progenitors 8.52
MYC dependent mRNA translation shapes gene expression and cell biology 8.5
Global unleashing of transcription elongation waves in response to genotoxic stress restricts somatic mutation rate 8.49
Expression data from fresh human embryonic lung epithelial tip and stalk cells and cultured organoids derived from tip and stalk. 8.33
IGF2BP3 controls cancer cell invasiveness by modulation RISC function 8.23
Proteinase-Activated Receptor 4 (PAR4) mediates cell membrane blebbing in a Gaq/11, Gai independent, RhoA and ß-arrestin-dependent manner. 8.22
Exploring transcriptomic landscapes in red cell populations, in their extracellular vesicles and on single cell level 8.22
MOV10 Is a 5' to 3' RNA Helicase Contributing to UPF1 mRNA Target Degradation by Translocation along 3'UTRs 8.08
MOV10 Is a 5' to 3' RNA Helicase Contributing to UPF1 mRNA Target Degradation by Translocation along 3'UTRs (expression) 8.08
Comparison of microRNA Profiling Platforms (HTS) 8.07
Comparison of microRNA Profiling Platforms 8.07
Transcriptome landscape of HeLa response upon triamcinolone acetonide 8.05
A radiolabeling-free, qPCR-based method for locus-specific pseudouridine detection 8.0
Capturing the Interactome of Newly Transcribed RNA 7.98
Capturing the Interactome of Newly Transcribed RNA (RICK) 7.98
Characterization and transplantation of enteric neural crest cells from human induced pluripotent stem cells 7.91
ERK potentiates transactivation and oncogenic function of ERG by phosphorylation induced dissociation of PRC2 complex 7.9
Elongation Factor TFIIS Prevents Transcription Stress and R-Loop Accumulation to Maintain Genome Stability [ RNA-seq] 7.88
Elongation Factor TFIIS Prevents Transcription Stress and R-Loop Accumulation to Maintain Genome Stability 7.88
HEK293 Heat-shock experiment 7.87
RNA sequencing of Formalin-Fixed, Paraffin-Embedded Specimens for Gene Expression Quantification and Data Mining 7.86
Gene expression in control and DOCK8 CRISPR KHYG1 NK cells 7.83
Transcriptomic hallmarks of tumor plasticity and stromal interactions in brain metastasis 7.8
RNA-Seq Analysis in hES/ iPS cell-derived neuronal samples 7.66
Next Generation Sequencing Facilitates Quantitative Analysis of mesoderm posterior bHLH transcription factor 1(MESP1)+ and MESP1- cells' Transcriptomes 7.45
RNA sequencing of heart samples of myotonic dystrophic (DM1) patients 7.44
The novel lncRNA lnc-NR2F1 is pro-neurogenic and mutated in human neurodevelopmental disorders [lnc-Nr2f1 overexpression] 7.43
The novel lncRNA lnc-NR2F1 is pro-neurogenic and mutated in human neurodevelopmental disorders 7.43
Integrative classification of human coding and non-coding genes based on RNA metabolism profiles 7.4
Measuring the effect of MYC on transcription during the DNA double-strand break response by RNA-seq of newly synthesized transcripts 7.36
Studying the selectivity of a targeted small molecule degrading a hypoxia-associated non-coding RNA 7.14
The cohesin release factor WAPL restricts chromatin loop extension. [RNA-Seq] 7.02
The cohesin release factor WAPL restricts chromatin loop extension. 7.02
quanTIseq: quantifying immune contexture of human tumors 6.98
The CDK7 Inhibitor THZ1 Alters RNA Polymerase Dynamics at the 5’ and 3’ Ends of Genes 6.97
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation [RNA-Seq SS] 6.96
Analysis and expansion of the eosinophilic esophagitis transcriptome by RNA sequencing 6.95
MiR-CLIP capture of a miRNA targetome uncovers a lincRNA H19-miR-106a interaction 6.94
Global transcriptional analysis and genome-wide analysis of chromatin state in extended pluripotent stem cells, primed pluripotent stem cells, and naïve pluripotent stem cells 6.91
Global transcriptional analysis of human extended pluripotent stem cells, human primed pluripotent stem cells, mouse extended pluripotent stem cells, and mouse embryonic stem cells by RNA-seq 6.91
Transcriptome analysis reveals determinant stages controlling human embryonic stem cell commitment to neuronal cells 6.87
lncRNA expression analysis in patients with eosinophilic and neutrophilic asthma 6.84
Folliculin regulates mTORC1/2 and WNT pathways in early human pluripotency 6.77
Transcriptomic analysis of human tonsillar TFH subsets 6.75
Potent and targeted activation of HIV-1 using the CRISPR/Cas9 activator Complex 6.7
Disease-associated mutation in SRSF2 misregulates splicing by altering RNA binding affinities 6.6
Canonical poly(A) polymerase activity promotes the decay of a wide variety of mammalian nuclear RNAs 6.58
Synaptic dysfunction in human neurons with Autism associated deletions in PTCHD1-AS 6.58
ENPP1 Mutation Causes Recessive Cole Disease by Altering Melanogenesis 6.57
Transcriptomic analysis of differential expressed genes of human tonsillar epithelial cells UT-SCC-60B in response to EV71 infection 6.56
RNA sequencing, chromatin accesibility and ChIP seq analysis of BAP1 -/- human liver organoids 6.55
RNA-seq analysis of gene expression patterns during hESC neural differentiation 6.44
hESC neural differentiation 6.44
Total RNA deep sequencing (ribosomal depleted) of human umbilical vein endothelial cells exposed to hypoxia (0.2%) for 12h and 24h or kept under normoxic conditions. 6.42
Endothelial gene expression analysis 6.42
Transcriptome of iPSC-derived Cerebral Organoids with Heterozygous Knockout in CHD8 6.39
Circular RNA expression signature of low-glucose-treated MIA PaCa-2 cells 6.37
RNA transcriptome sequencing analysis of SGC-7901 cells transfected with tcons_00001221 shRNA or control shRNA 6.37
TrapSeq: An RNA Sequencing-based pipeline for the identification of genetrap insertions in mammalian cells 6.29
Genetic and Epigenetic Landscapes of Laterally Spreading Tumors of the Colorectum 6.24
Gene expression analysis of human hepatocellular cancers 6.22
Differential responses by human respiratory epithelial cell lines to respiratory syncytial virus reflect distinct patterns of infection control 6.13
Gene expression profile in breast cancer cells 6.07
Genome-wide profile of cJun and p27 and gene expression profile in breast cancer cells 6.07
mRNA-sequencing of breast cancer subtypes and normal tissue 6.02
The phosphatidylinositol 3-kinase pathway as a potential therapeutic target in bladder cancer 5.97
Transcription elongation regulates genome 3D structure 5.82
Novel Transcriptional Activity and Extensive Allelic Imbalance in the Human MHC Region 5.79
RNAseq of ribosomal fractionation to assess the effect of CBFB on translation regulation 5.77
Transcriptome analysis reveals differential splicing events in IPF lung tissue 5.69
Transcriptome analysis upon C6orf203 silencing 5.66
Activation of neuronal genes via LINE-1 elements upon global DNA demethylation in human neural progenitors 5.6
FGF2 regulation of gene expression in stable inducible Neurons 5.59
Apolipoprotein E4 Expression Causes Gain of Toxic Function in Isogenic Human Induced Pluripotent Stem Cell-Derived Endothelial Cells 5.57
A Novel Population of Human Cardiac Resident Mesenchymal Stem Cells 5.48
Patient-iPSC-derived kidney organoids show functional validation of a ciliopathic renal phenotype 5.38
Runx1 stabilizes the mammary epithelial cell phenotype and prevents epithelial to mesenchymal transition 5.36
RNA sequencing of human mammary epithelial cells 5.36
Genomic expression analysis of K562 cells expressing shRNA targeting lncRNA-IIRX and control cells 5.33
RNA-Seq profiling in PBMCs and spinal cord from ALS patients and healthy controls 5.18
Comprehensive RNA-Seq profiling in PBMCs of ALS patients and healthy controls 5.18
Be1 and Be2 B cells are transcriptionally distinct 5.17
PRC2 specifies ectoderm lineages and maintains pluripotency in primed but not naïve ESCs 5.1
mRNA gene expression profiling in a human AML cell line treated with small molecule inhibitors that impact different RNA polymerase transcription complexes, or their combination, in comparison to a global DNA-damaging anthracycline compound 4.9
MiR-CLIP capture of a miRNA targetome uncovers a lincRNA H19-miR-106a interaction [III] 4.81
RNA-Seq of CD4+ T cells treated with AS1842856 or DMSO 4.81
High-throughput sequencing of PROMPT-enriched samples. 4.77
Identification of miRNA signatures during the differentiation of hESCs into retinal pigment epithelial cells 4.67
Zika virus directly infects human peripheral neurons and induces cell death 4.63
Gene expression in skeletal muscle in older individuals subject to ten days of complete bed rest. 4.6
Cis-Regulatory Circuits Regulating NEK6 Kinase Overexpression in Transformed B Cells Are Super-Enhancer-Independent (RNA-seq) 4.51
Cis-Regulatory Circuits Regulating NEK6 Kinase Overexpression in Transformed B Cells Are Super-Enhancer-Independent 4.51
An alternative CTCF isoform antagonizes canonical CTCF occupancy and changes chromatin architecture to promote apoptosis 4.49
Human gut derived-organoids as model to study gluten response and effects of microbiota bioproducts in celiac disease 4.4
Triple vectors expand AAV transfer capacity in the retina 4.4
lncRNA-PCAT1 knockdown effect on the gene expression of androgen independent LNCaP (LNCaP-AI) cell line 4.34
Whole blood stabilization for the microfluidic isolation and molecular characterization of circulating tumor cells 4.31
Oncogenic Antisense LncRNA P14AS Regulates Expression of ANRIL through AUF1 Binding 4.26
Transcriptomic analysis of human iPS cells derived from fragile X syndrome patients during neural differentiation 4.18
RNA-Seq profiling of days 0, 7 and 18 kidney organoids differentiated from three separate vials of starting material 4.05
High-Throughput Screening of Human Induced Pluripotent Stem Cell Cardiomyocytes Predicts Tyrosine Kinase Inhibitor Cardiotoxicity 3.93
Tyrosine Kinase Inhibitor Cardiotoxicity 3.93
Knockout of miR-221 and miR-222 reveals overlapping and specific function between paralogous miRNAs 3.92
4sUDRB-seq: measuring transcription elongation and initiation genomewide 3.9
Toxoplasma controls host cyclin E expression through the use of a novel MYR1-dependent effector protein, HCE1 3.86
tRNA modification landscape selectively controls mitochondrial translation efficiency in MERRF 3.81
Comparative gene expression profiling of human primary endotheliocytes cultivated on polyurethane-based electrospun 3D matrices and natural decellularized vein 3.8
Class I histone deacetylases HDAC1, 2 and 3 are histone decrotonylases 3.75
Human iPSC-derived cells and microengineered Organ-Chip enhance neural development. 3.72
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation 3.62
Low carbohydrate diet study for non-alcoholic fatty liver disease patients 3.61
The acetyllysine reader BRD3R promotes human nuclear reprogramming and regulates mitosis 3.47
Prolyl Hydroxylase Substrate Adenylosuccinate Lyase Is An Oncogenic Driver In Triple Negative Breast Cancer 3.46
HMGA1 and FOXM1 synergistically regulate a common gene network modulating angiogenesis in breast cancer 3.41
Rnase L reprograms translation by widespread mRNA turnover escaped by antiviral mRNAs 3.33
CRISPR activation of long non-coding RNAs transiently expressed during cortical neuron differentiation associated with Field, et al, Stem Cell Reports 2018 3.32
RNA-seq analysis of RALD iPSCs after in vitro differentiation 3.29
Robust generation of honemogeneous midbrain organoids with in vivo–like cellular composition facilitates neurotoxin-based Parkinson’s disease modeling 3.28
A549 cell transcriptome responses to infection with H7N9 influenza virus 3.26
Transcriptome analysis of Riociguat and Vehicle control treatment in human hematopoietic stem and progenitor cells 3.25
RG/RGG boxes are common binding motifs in RNA-G-quadruplex-interacting proteins 3.19
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 3.14
A cytoplasmic COMPASS is necessary for cell survival and triple-negative breast cancer pathogenesis by regulating metabolism 3.13
MPTAC determines APP fragmentation via sensing sulfur amino acid catabolism 3.1
Transcriptomes of human monocytes and monocyte-derived macrophages with or without glucocorticoid treatment 3.07
RNA-seq analysis of SKMEL28 melanoma cells following DIRC3 and IGFBP5 ASO knockdown 2.93
BRD9 defines a novel SWI/SNF sub-complex and constitutes a specific vulnerability in malignant rhabdoid tumors 2.87
Analysis of human ES cell differentiation establishes that the dominant isoforms of the lncRNAs RMST and FIRRE are circular 2.85
Long-term in vitro expansion of epithelial stem cells enabled by pharmacological inhibition of PAK1-ROCK-Myosin II and TGF-β signaling (RNA-seq) 2.84
Long-term in vitro expansion of epithelial stem cells enabled by pharmacological inhibition of PAK1-ROCK-Myosin II and TGF-β signaling 2.84
The DPYSL2 gene connects mTOR and schizophrenia 2.82
Analysis of gene expression in SKOV3 ovarian cancer cells after knockdown of the long non-coding RNA DNM3OS 2.79
A monocyte gene expression signature in the early clinical course of Parkinson’s disease 2.77
Peripheral whole blood mRNAs and lncRNAs expression analysis in eosinophilic asthmatics 2.74
The role of the Calcium-Sensing receptor in colorectal cancer 2.73
Ribosome Incorporation into Somatic Cells Promotes Lineage Transdifferentiation towards Multipotency 2.67
Ribosome Incorporation into Somatic Cells Promotes Lineage Transdifferentiation towards Multipotency [RNA-Seq] 2.67
Inhibition of the integrin alpha-V beta-3 reverts the paradoxical effect of levothyroxine replacement during bexarotene therapy in cutaneous T-cell lymphoma 2.63
Pro-angiogenic Ginsenoside F1 and Rh1 Inhibit Vascular Leakage by Modulating NR4A1 2.63
Muscle transcriptome analysis following Total Knee Arthroplasty with Tourniquet 2.61
Thyroid State Regulates Gene Expression in Human Whole Blood Cells 2.55
Influenza Vaccination Primes Human Myeloid Cell Cytokine Secretion and Natural Killer Cell Function 2.51
Assessing placental maturity through histological and transcriptomic analyses in idiopathic spontaneous preterm birth 2.43
Epigenomes and transcriptomes of human monocytes before and after in vivo exposure to Bacillus Calmette-Guérin vaccine 2.4
Expression of the mannose receptor (CD206) defines distinct populations of human colonic macrophages in health and inflammatory bowel disease 2.37
Comparing effects of perfusion and hydrostatic pressure on human chondrocytes using gene profiles 2.22
Genome-wide MAF1-dependent regulation of RNA polymerase III transcription 2.19
Genome-wide MAF1-dependent regulation of RNA polymerase III transcription [RNA-Seq] 2.19
Profiling in vivo Bone Lesion (IVBL) and Orthotopic tumors by Next Generation Sequencing 2.19
SREBP1 drives Keratin 80-dependent cytoskeletal changes and invasive behavior in endocrine resistant ERα breast cancer 2.14
Pharmacological Induction of a Progenitor State for the Efficient Expansion of Primary Human Hepatocytes 2.14
Transcriptome-wide profiling of poly(A)-tail length, translation efficiency and mRNA stability using TED-seq, mRNA-seq, Ribo-seq and PRO-seq in ER stress conditions 2.13
Simultaneous and systematic analysis of cellular and viral gene expression during Enterovirus 71-induced host shutoff 2.08
Transcriptional study of ARN8 cells treated with novel DHODH inhibitors 2.05
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia [inhibitor MRT199665] 1.96
Coordinated regulation of synthesis and stability of RNA during the acute TNF-induced proinflammatory response 1.95
Integration of ATAC-seq and RNA-seq Identifies Human Alpha Cell and Beta Cell Signature Genes 1.87
Comparison of small cell lung cancer PDX model FHSC04 for response to LSD1 inhibitor RG6016/ORY1001 1.84
The global transcriptome analysis in the time course of hESC-derived cardiac differentiation 1.82
Epigenetic activation and memory at a TGFB2 enhancer in systemic sclerosis 1.82
mRNA-Seq profiling of human developing kidney 1.78
mRNA-Seq profiling SIX2+ and Foxd1+ cells in mouse embryonic and SIX2+ and SIX2-/MEIS1+ cells human fetal kidney 1.7
Engineered Nanointerfaces for Microfluidic Isolation and Molecular Profiling of Tumor-specific Extracellular Vesicles 1.65
RNA-seq analysis of hPSC-derived brain pericyte-like cells, hPSC-derived neural crest stem cells, and primary human brain pericytes 1.64
RNA-Seq following PCR-based sorting reveals rare cell transcriptional signatures 1.62
Myc activation coordinates gene transcription and protein translation responses 1.56
BRD9 defines a novel SWI/SNF sub-complex and constitutes a specific vulnerability in malignant rhabdoid tumors [RNA-seq 2] 1.55
Patient-derived xenograft models of non-small cell lung cancer for evaluating targeted drug sensitivity and resistance 1.52
mRNA sequencing of oropharyngeal cancer cell lines 1.5
Identification of trans regulators of ADAR and A-to-I RNA editing using RNA-seq 1.46
Unbiased identification of trans regulators of ADAR and A-to-I RNA editing 1.46
Zoledronic acid inhibits NFAT and IL-2 signaling pathways in regulatory T cells and diminishes their suppressive function in patients with metastatic cancer 1.43
LHX9 rescues KRAS suppression through transcriptional regulation of YAP1 [RNA-Seq] 1.38
LHX9 rescues KRAS suppression through transcriptional regulation of YAP1 1.38
Universal alternative splicing of noncoding exons 1.37
Long noncoding RNA ROCR contributes to SOX9 expression and chondrogenic differentiation of human mesenchymal stem cells 1.31
RNA-seq of Human neck of femur (NOF) fracture hip and osteoarthritic (OA) cartilage 1.31
Expression data for HT29 cells treated with 5-aza-deoxy-cytidine [RNA-Seq] 1.31
Expression data for HT29 cells treated with 5-aza-deoxy-cytidine 1.31
Transcriptomic analysis of inter- and intra-patient variation in human iPSC cardiomyocytes: Platform for precision medicine to predict drug toxicity 1.21
Antiviral and anti-inflammatory properties of novel anti-HIV candidate ABX464 promotes specifics RNA splicing while preserving cellular RNA integrity. 1.2
Transcriptome-wide discovery of microRNA binding sites in human brain by Ago2 HITS-CLIP 1.19
nELAVL HITS-CLIP in Alzheimer's Disease patients 1.11
Splicing and gene expression changes in human mammary epithelial MCF-10A cells expressing SR or SR-like proteins 0.99
A single-cell transcriptome atlas of the human pancreas 0.97
Transcription factors and stress response gene alterations in human keratinocytes following Solar Simulated Ultra Violet Radiation 0.9
Genome-Wide Specificity of DNA-Binding, Gene Regulation, and Chromatin Remodeling by TALE- and CRISPR/Cas9-Based Transcription Factors 0.87
Expression profiling of pancreatic adenocarcinoma and ductal adenocarcinoma cell lines. 0.74
MiR-26 dampens IL-6 production by down-regulating TNF-a/NF-kB signaling through silencing HMGA1 and MALT1 and not by directly targeting IL-6 mRNA 0.73
CX3CR1/Fractalkine receptor expression separates memory CD8+ T cells with distinct functional profiles (RNA-seq) 0.71
CX3CR1/Fractalkine receptor expression separates memory CD8+ T cells with distinct functional profiles 0.71
Widespread Transcription beyond mRNA 3’ Ends Yields Abundant Regulatory RNAs 0.71
Gene expression profiles in NORAD knockout and PUMILIO overexpressing cells 0.7
Transcriptome profiling of A2M treated A549 Cell Line Samples 0.66
Urinary sediment transcriptomic and longitudinal data to investigate renal function decline in type 1 diabetes 0.64
Genomic profiling of biliary tract cancer cell lines reveals molecular subtypes and actionable drug targets 0.64
Deep sequencing of transcript levels in pluripotent stem cells and their differentiated derivatives in all three germ layers 0.63
A Low-cost Multiplex Biomarker Assay Stratifies Colorectal Cancer Patient Samples into Clinically-relevant Subtypes: Singapore Cohort RNA-seq 0.59
A Low-cost Multiplex Biomarker Assay Stratifies Colorectal Cancer Patient Samples into Clinically-relevant Subtypes 0.59
Sirt6 Oncogene Mediates PI3K/Akt Signaling Activation in Diffuse Large B-Cell Lymphoma 0.58
The transcriptomic landscape of MAIT cell development in the thymus (C006 RNAseq data set) 0.55
RNA-seq analysis in Cornea epithelial cells (CECs), skin epithelial cells (SECs), LSCs after knocking down PAX6 (3-D shPAX6 LSCs) and SESCs transduced with PAX6(3-D PAX6+ SESCs) upon 3-D differentiation 0.5
miR-126 Orchestrates an Oncogenic Program in B-Cell Precursor Acute Lymphoblastic Leukemia 0.48
Dynamics of MBD2 deposition across methylated DNA regions during malignant transformation of human mammary epithelial cells 0.46
Dynamics of MBD2 deposition across methylated DNA regions during malignant transformation of human mammary epithelial cells (2) 0.46
Human Tfh cell RNA bulk sequencing 0.42
Hsa-miR-139-5p/HNRNPF axis modulates gene-transcripts balance in thyroid cancer cells 0.38
Global gene expression profile of dasatinib-resistant RCH-ACV cells 0.37
Low-Cell-Number, Single-Tube Amplification (STA) of RNAs Revealed miRNA Changes from Pluripotency to Endothelium 0.36
Transcriptomic profile of intestinal epithelial cells obtained from ileal endoscopic biopsies from newly-diagnosed, pediatric Crohn's disease patients and healthy controls. 0.34
Long Non-coding RNA PICSAR Promotes Growth of Cutaneous Squamous Cell Carcinoma by Regulating ERK1/2 Activity 0.33
Sex-specific gene expression differences are evident in human embryonic stem cells and during in vitro differentiation of human placental progenitor cells 0.25
mRNA sequencing of the mouse and human Hep-Orgs, Chol-Orgs and primary hepatocytes 0.24
Post-transcriptional remodelling is temporally deregulated during motor neurogenesis in human ALS models 0.16
Transcriptome analysis in a radiosensitive and a radioresistant cell line after ionizing radiation 0.14
The effect of doxycycline-induced expression of host-cell-factor 2 (HCF-2) proteins on the global gene expression in HEK-293 cells 0.1
RNA sequencing of hiPSC derived neural crest populations from Familial Dysautonomia patients 0.1
CNOT1 and Transcriptomic Landscape of a HeLa Cell Line 0.06
Comparing oestrogen-responsive genes in endometrial and breast cancer cell lines 0.01


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation